Medical Business: Pharmaceutical Companies To Find A Good Agent Products
"The new medical reform" program for further compression Medicine The middle part of the description of business profits, "provincial hanging net" Tender The national launch, the community, "the new rural cooperative" concentration distribution, trends, mean that the original commercial pharmaceutical business companies must transition to adapt to the new needs of the situation, by "spread-based earnings" model to the "Shipping profit, "the transition, some can not get the right distribution of small and medium pharmaceutical companies need to re-adjust their thinking to adapt to new medical developments.
Such as pharmaceutical companies greatly expanded the original business, "total Proxy "The business is a good trend. Therefore, to find a good product to do the national distributor, has become the most important task of all things. So how to find highly profitable, exclusive, or patent protection, trade the successful long-term varieties of it? author to provide some reference for this operation method.
First of all, located in the direction of such pharmaceutical companies can set up a special variety selection and negotiating team members can be in-house marketing department or other department staff part-time, its priorities are: always watch "National Drug review of the center "of drugs for approval, review status; regular contact with large domestic pharmaceutical R & D companies, pharmaceutical colleges discussion group, Chinese Academy of Sciences, Military Medical Academy and other well-known pharmaceutical research institutions established projects, the newspaper Variety, the transfer dynamics and research project's intention to buyers, and so forth. Do such work can help pharmaceutical companies from the source control agent the next 3-5 years, drug listing information, but also provide a large number of alternative negotiation Quanguozongdai opportunity, because the really good variety of agency project from the project had already started to negotiate or sign a contract agent for the species symbol down on the home agent can only act as agent complementary role of the market, described as "the outcome of the war before the war actually decided."
Second, should actively contact the well-known multinational pharmaceutical company's headquarters and its institutions such as the Asia-Pacific marketing director, actively negotiating some of these multinational corporations the right of the leading pharmaceutical distributor in China, such as China 90 years of "Shenzhen Kin Medicine "" Pioneer Medicine "," Cabernet Franc medicine "and other companies are founded and grow this model, and these patterns are also common in the international arena, such as" Yongyu Medicine "," Jebsen "," DCH Matheson, "and so on.
Third, we must actively relate the discussion of domestic large pharmaceutical companies. Many large pharmaceutical companies in recent years has been submitted for approval, or in the newspaper many varieties, small and medium sized pharmaceutical companies signed earlier with the right agent. A typical example of such pharmaceutical companies are: "Henry pharmacy", "North China Pharmaceutical [8.970.79 %]"," suburban district of Hangzhou [10.600.09%] medicine," and others. This agent model of a typical representative of such are: "Shenzhen Langou medicine", "Jiangsu Curphey Ping medicine" and other companies, such varieties if the agent is Traditional Chinese medicine Products, often have a strong competitive edge, or is the medicine of the protected variety, or is the exclusive variety, tender an advantage. "Beijing Yongzheng medicine" General on behalf of the "suburban district of Hangzhou medicine" and "little golden capsule" "will Capsule", through the distribution of investment to the country was part of this pattern.
Fourth, the small and medium sized pharmaceutical companies also actively negotiating for the domestic joint ventures, wholly-owned multinational Pharmaceutical companies Second-line products, these products often is the exclusive or patented varieties, the pricing, tender and even the hospital and other links have unique advantages, and these species belongs to the multinational pharmaceutical companies in self-built Sell Team to take into account the variety, however, so the total generation of such products once the right, the generally long-term variety, since these products need to do long-term academic promotion, the agents should have enough patience to spend around 2 years input stage, can not do these products make a quick profit agency.
Specific to such products sales model is really almost the same as self-built factory team approach, whether the establishment of the sales team, or the establishment of expert networks and applications, all to promote a series of academic work required by the Director on behalf of the operators to complete typical example of such models have "Fahrenheit Yangpu pharmaceutical company."
For small and medium sized Chinese commercial companies, can play a regional business advantage, expand regional pharmaceutical distributor business to make up for distribution after failing to get the right result in marked decrease in profit.
I am China Quality Digital writer, reports some information about roland cutter plotter , pvc card printers.